ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,727Medicare Part D Prescriptions Filled, Including Refills

Rank: 167 out of 1000

$661K Total Retail Price of All Prescriptions

Rank: 158 out of 1000

507 Patients Receiving at Least One Drug in Part D
65%Patients 65 Years and Older
51% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 507 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

20% of this provider’s 507 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

2% of this provider’s 8,326 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
SIMVASTATIN 545 342 1 3
OMEPRAZOLE 518 328 2 2
HYDROCODONE-ACETAMINOPHEN 456 223 S3 3 1
ZOLPIDEM TARTRATE 403 267 4 16
AMLODIPINE BESYLATE 391 295 5 6
HYDROCHLOROTHIAZIDE 347 251 6 9
METFORMIN HCL 330 200 7 8
LISINOPRIL-HYDROCHLOROTHIAZIDE 299 229 8 20
PRAVASTATIN SODIUM 263 216 9 12
CITALOPRAM HBR 263 184 9 17
LEVOTHYROXINE SODIUM 262 177 11 4
LISINOPRIL 246 160 12 5
LOSARTAN POTASSIUM 237 168 13 25
POTASSIUM CHLORIDE 231 142 14 10
PANTOPRAZOLE SODIUM 196 94 15 28
NEXIUM 180 81 16 23
TRAMADOL HCL 178 109 17 13
GABAPENTIN 167 98 18 11
MELOXICAM 160 73 19 14
LOSARTAN-HYDROCHLOROTHIAZIDE 159 99 20 38
CARVEDILOL 158 83 21 15
GLIMEPIRIDE 157 111 22 34
CHLORTHALIDONE 143 83 23 174
AMITRIPTYLINE HCL 140 56 R 24 45
BENAZEPRIL HCL 140 89 24 61
FLUTICASONE PROPIONATE 124 70 26 40
TAMSULOSIN HCL 119 102 27 33
METOPROLOL SUCCINATE 113 96 28 21
VERAPAMIL ER 111 79 29 86
FUROSEMIDE 110 80 30 7
ATORVASTATIN CALCIUM 108 82 31 18
ALLOPURINOL 107 64 32 31
METFORMIN HCL ER 106 73 33 44
SERTRALINE HCL 106 67 33 26
RANITIDINE HCL 93 21 35 37
BENAZEPRIL-HYDROCHLOROTHIAZIDE 92 67 36 175
LYRICA 87 47 37 47
CYCLOBENZAPRINE HCL 86 19 R 38 39
TRAZODONE HCL 84 58 39 29
METOPROLOL TARTRATE 84 53 39 19
ATENOLOL 78 62 41 24
GEMFIBROZIL 77 37 42 105
GLIPIZIDE ER 76 57 43 106
ADVAIR DISKUS 74 0 44 65
CYMBALTA 71 16 45 53
PAROXETINE HCL 70 61 46 63
PROAIR HFA 70 35 46 50
AMLODIPINE BESYLATE-BENAZEPRIL 67 67 48 59
FENTANYL 66 11 S2 49 100
SPIRIVA 65 34 50 64
ENDOCET 65 35 S2 50 107
ISOSORBIDE MONONITRATE ER 65 24 50 71
BUMETANIDE 65 47 50 112
LANTUS SOLOSTAR 65 42 50 120
PREDNISONE 64 43 55 42
SPIRONOLACTONE 64 29 55 78
PROPRANOLOL HCL 64 49 55 135
VENTOLIN HFA 63 0 58 83
TRIAMTERENE-HCTZ 62 25 59 48
CRESTOR 61 41 60 30
INSULIN SYRINGE 60 25 61 93
FAMOTIDINE 59 49 62 88
CLOPIDOGREL 58 47 63 35
INDAPAMIDE 57 57 64 164
WARFARIN SODIUM 56 40 65 22
FLUOXETINE HCL 56 23 65 51
FELODIPINE ER 56 56 65 210
TRANDOLAPRIL 55 50 68 352
OXYCONTIN 54 29 S2 69 166
VENLAFAXINE HCL ER 52 0 70 124
PLAVIX 51 33 71 49
MOEXIPRIL-HYDROCHLOROTHIAZIDE 50 48 72 340
LIPITOR 50 42 72 170
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 7, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.